BWL
SRPT icon

Bogart Wealth LLC’s Sarepta Therapeutics SRPT Stock Holding History

Bogart Wealth LLC’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8
Closed -$137 – 1587
2025
Q2 		$137 Buy
+8
New +$341 ﹤0.01% 1420
2023
Q4 		– Sell
-39
Closed -$4.73K – 1121
2023
Q3 		$4.73K Sell
39
-40
-51% -$4.52K ﹤0.01% 727
2023
Q2 		$9.05K Buy
79
+49
+163% +$6.32K ﹤0.01% 604
2023
Q1 		$4.13K Hold
30
– – ﹤0.01% 756
2022
Q4 		$3.89K Hold
30
– – ﹤0.01% 708
2022
Q3 		$3K Buy
+30
New +$3.02K ﹤0.01% 791

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Bogart Wealth LLC's SRPT Position: Q3 2025 in Review

Bogart Wealth LLC sold out of Sarepta Therapeutics (SRPT) in Q3 2025, closing a stake of 8 shares — an estimated $137 sold.

Bogart Wealth LLC first reported a position in SRPT in Q3 2022 and held it in 6 quarters. The position peaked at $9.05K in Q2 2023. 319 funds tracked by Wall St. Rank hold SRPT as of Q3 2025.

  • Bogart Wealth LLC reported no remaining Sarepta Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Bogart Wealth LLC sold 8 Sarepta Therapeutics shares in Q3 2025, an estimated $137.
  • Bogart Wealth LLC first reported a position in Sarepta Therapeutics in Q3 2022 and held it in 6 quarters.
  • Bogart Wealth LLC's Sarepta Therapeutics position peaked at $9.05K in Q2 2023.
  • 319 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2025.

Based on Bogart Wealth LLC's 13F filing for Q3 2025, filed 27 Oct 2025.